WallStreetZenWallStreetZen

NASDAQ: BRVE
Braveheart Bio Inc Stock Ownership - Who owns Braveheart Bio?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Braveheart Bio Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Ah Bio Fund IV LP10% Owner2026-08-071,100,000$18.00
$19.80MBuy
Michele A. AndersonCXO2026-08-071,111$18.00
$20.00kBuy
Erez ChimovitsDirector2026-08-071,666,667$18.00
$30.00MBuy
Erez ChimovitsDirector2026-08-07273,333$18.00
$4.92MBuy
Forbion Growth Opportunities Fund III Cooperatief Ua10% Owner2026-08-071,920,000$18.00
$34.56MBuy
Forbion Growth Opportunities Fund III Cooperatief Ua10% Owner2026-08-071,680,000$18.00
$30.24MBuy
David Charles LubnerDirector2026-08-0755,555$18.00
$999.99kBuy
David I. MalekDirector2026-08-074,166$18.00
$74.99kBuy
Travis MurdochCEO;Pres2026-08-0783,333$18.00
$1.50MBuy
Orbimed Advisors LLCDirector2026-08-071,666,667$18.00
$30.00MBuy

1 of 2

BRVE insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when BRVE insiders and whales buy or sell their stock.

BRVE Shareholders

What type of owners hold Braveheart Bio Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Forbion Growth Opportunities Fund III Cooperatief Ua24.24%21,826,024$510.07MInsider
Vineeta Agarwala11.36%10,232,420$239.13MInsider
Ah Bio Fund IV LP11.36%10,232,420$239.13MInsider
Travis Murdoch9.26%8,333,637$194.76MInsider
Jiangsu Hengrui Pharmaceuticals Co Ltd8.24%7,420,091$173.41MInsider
Erez Chimovits1.53%1,376,072$32.16MInsider
Jason V. Coloma1.22%1,100,456$25.72MInsider
David I. Malek1.13%1,013,297$23.68MInsider
Christopher Viehbacher0.84%759,857$17.76MInsider
James Paul Rickey0.78%703,575$16.44MInsider

1 of 2

BRVE vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
BRVE0.00%70.70%Net BuyingNet Buying
ZYME0.10%93.89%Net SellingNet Buying
FTRE0.11%1.15%Net SellingNet Selling
VIR0.09%30.90%Net Selling
LKFT0.05%0.00%
View Top Biotech Stocks

Braveheart Bio Stock Ownership FAQ

Who owns Braveheart Bio?

Braveheart Bio (NASDAQ: BRVE) is owned by 0.00% institutional shareholders, 70.70% Braveheart Bio insiders, and 29.30% retail investors. Forbion Growth Opportunities Fund III Cooperatief Ua is the largest individual Braveheart Bio shareholder, owning 21.83M shares representing 24.24% of the company. Forbion Growth Opportunities Fund III Cooperatief Ua's Braveheart Bio shares are currently valued at $450.05M.

If you're new to stock investing, here's how to buy Braveheart Bio stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.